| Impact of COVID-19 prevention measures on risk of health care-associated Clostridium difficile infection E Bentivegna, G Alessio, V Spuntarelli, M Luciani, I Santino, M Simmaco, ... American journal of infection control 49 (5), 640-642, 2021 | 102 | 2021 |
| Reduction of multidrug-resistant (MDR) bacterial infections during the COVID-19 pandemic: a retrospective study E Bentivegna, M Luciani, L Arcari, I Santino, M Simmaco, P Martelletti International journal of environmental research and public health 18 (3), 1003, 2021 | 96 | 2021 |
| Long-COVID headache P Martelletti, E Bentivegna, V Spuntarelli, M Luciani SN Comprehensive Clinical Medicine 3 (8), 1704-1706, 2021 | 63 | 2021 |
| New IgM seroconversion and positive RT‐PCR test after exposure to the virus in recovered COVID‐19 patient E Bentivegna, A Sentimentale, M Luciani, ML Speranza, L Guerritore, ... Journal of medical virology 93 (1), 97, 2021 | 63 | 2021 |
| Incidence and determinants of high-sensitivity troponin and natriuretic peptides elevation at admission in hospitalized COVID-19 pneumonia patients L Arcari, M Luciani, L Cacciotti, MB Musumeci, V Spuntarelli, E Pistella, ... Internal and emergency medicine 15, 1467-1476, 2020 | 47 | 2020 |
| COVID-19: is it just a lung disease? A case-based review V Spuntarelli, M Luciani, E Bentivegna, V Marini, F Falangone, G Conforti, ... SN Comprehensive Clinical Medicine 2 (9), 1401-1406, 2020 | 41 | 2020 |
| Coinfection of tuberculosis pneumonia and COVID-19 in a patient vaccinated with Bacille Calmette-Guérin (BCG): case report M Luciani, E Bentivegna, V Spuntarelli, P Amoriello Lamberti, L Guerritore, ... SN comprehensive clinical medicine 2, 2419-2422, 2020 | 34 | 2020 |
| Extremely severe case of COVID-19 pneumonia recovered despite bad prognostic indicators: a didactic report E Bentivegna, M Luciani, V Spuntarelli, ML Speranza, L Guerritore, ... Sn Comprehensive Clinical Medicine 2 (8), 1204-1207, 2020 | 26 | 2020 |
| Headache as a Prognostic Factor for COVID-19. Time to Re-evaluate P Martelletti, E Bentivegna, M Luciani, V Spuntarelli SN Comprehensive Clinical Medicine 2, 2509-2510, 2020 | 25 | 2020 |
| Recurrent COVID‐19 pneumonia in the course of chemotherapy: Consequence of a weakened immune system? M Luciani, E Bentivegna, V Spuntarelli, PA Lamberti, G Cacioli, ... Journal of Medical Virology 93 (4), 1882, 2021 | 24 | 2021 |
| Recent advancements in tension-type headache: a narrative review E Bentivegna, M Luciani, V Paragliola, F Baldari, PA Lamberti, G Conforti, ... Expert review of neurotherapeutics 21 (7), 793-803, 2021 | 22 | 2021 |
| Position paper on post-traumatic headache: the relationship between head trauma, stress disorder, and migraine G Lambru, S Benemei, AP Andreou, M Luciani, G Serafini, ... Pain and therapy 10, 1-13, 2021 | 19 | 2021 |
| Deprescribing in migraine P Martelletti, M Luciani, V Spuntarelli, E Bentivegna Expert Opinion on Drug Safety 20 (6), 623-625, 2021 | 18 | 2021 |
| Longitudinal changes of left and right cardiac structure and function in patients with end-stage renal disease on replacement therapy L Arcari, GM Ciavarella, S Altieri, LR Limite, D Russo, M Luciani, ... European Journal of Internal Medicine 78, 95-100, 2020 | 18 | 2020 |
| Evaluating and managing severe headache in the emergency department M Luciani, A Negro, V Spuntarelli, E Bentivegna, P Martelletti Expert Review of Neurotherapeutics 21 (3), 277-285, 2021 | 16 | 2021 |
| Coronavirus disease 2019 in patients with cardiovascular disease: clinical features and implications on cardiac biomarkers assessment L Arcari, M Luciani, L Cacciotti, M Pucci, MB Musumeci, L Pietropaolo, ... Journal of Cardiovascular Medicine 22 (11), 832-839, 2021 | 15 | 2021 |
| Hormonal therapies in migraine management: current perspectives on patient selection and risk management E Bentivegna, M Luciani, F Scarso, C Bruscia, D Chiappino, E Amore, ... Expert Review of Neurotherapeutics 21 (12), 1347-1355, 2021 | 7 | 2021 |
| Eptinezumab for the treatment of migraine V Spuntarelli, A Negro, M Luciani, E Bentivegna, P Martelletti Expert Opinion on Biological Therapy 21 (8), 999-1011, 2021 | 7 | 2021 |
| The point-of-care ultrasound (POCUS) by the handheld ultrasound devices (HUDs) in the COVID-19 scenario: a review of the literature A Martocchia, E Bentivegna, D Sergi, M Luciani, M Barlattani, ... SN Comprehensive Clinical Medicine 5 (1), 1, 2022 | 5 | 2022 |
| Recently approved and emerging drug options for migraine prophylaxis E Bentivegna, M Luciani, V Ferrari, S Galastri, F Baldari, F Scarso, ... Expert Opinion on Pharmacotherapy 23 (11), 1325-1335, 2022 | 5 | 2022 |
Enrico BentivegnaSapienza UniversityVerified email at uniroma1.it
